Company News
Location:
Home
News
Company News
Laviana Pharma technology innovation yields fruitful results again, with three patents granted national intellectual property authorization.

Recently, Laviana Pharma successfully obtained three national patents, namely "Preparation method of tetrahydropyrrolo[3.4-b]quinazolinone", "A hydrogenation reaction kettle", and "Synthesis method of 1.2.4.5-tetrazine compounds". The acquisition of these patents marks a breakthrough in the company's technological innovation, further promoting the overall improvement of research and development quality and production efficiency.


1734939327401137.png


Laviana Pharma  always regards innovation as the core driving force for enterprise development, Changing the World with the Art of Chemistry , promoting the upgrading and transformation of the pharmaceutical industry. As of now, the company has obtained a total of 63 patents, with over 23 additional patents under re-examination.


1734939363729936.png


Laviana Pharma has adhered to the path of innovation for nearly 20 years, consistently upholding the philosophy of open cooperation. It has established extensive collaborative relationships with well-known enterprises and research institutions at home and abroad. Actively promoting a collaborative innovation model, it is committed to transforming scientific research achievements into practical applications and insists on empowering high-quality development of enterprises through technological innovation.


1734939391960895.png


The acquisition of intellectual property not only helps companies improve their intellectual property protection systems and leverage their advantages in independent intellectual property, but also significantly enhances their core competitiveness. In the future, Laviana Pharma  will continue to adhere to scientific innovation, continuously increase R&D investment, use benchmarking innovation as a means, and adopt combined innovation as an engine to continuously improve independent innovation capabilities and promote high-quality development of the enterprise.